The latest research suggests that the recombinant shingles vaccine may offer additional benefits. It appears to reduce the ...

The risk for incident gout following RZV exposure was not increased among adults aged 50 years or older, according to study findings.

Older people who avail themselves of the newest shingles vaccine could reap a hidden benefit: A significant drop in their ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines.

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of its Herpes Zoster vaccine, Shingrix ...

Vaccination with GSK's recombinant shingles vaccine, Shingrix, could delay the onset of dementia, according to researchers in the UK. A study published in Nature Medicine suggests that people ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax), By Type (Recombinant Vaccine), By End-use (Private ...

GSK has launched it's Shingles vaccine in Malaysia and here's all you need to know about it. From what it is, to the side ...

7 An estimated one million people develop shingles annually in the US. 8 About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in ...

7 An estimated one million people develop shingles annually in the US. 8 About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the ...